Strikić Đula Ivana, Pleić Nikolina, Babić Leko Mirjana, Gunjača Ivana, Torlak Vesela, Brdar Dubravka, Punda Ante, Polašek Ozren, Hayward Caroline, Zemunik Tatijana
Health Center Sibenik, 22 000 Sibenik, Croatia.
Department of Medical Biology, School of Medicine, University of Split, 21 000 Split, Croatia.
Biology (Basel). 2022 Mar 2;11(3):394. doi: 10.3390/biology11030394.
Thyroid dysfunction appears to be the leading endocrine disorder. We conducted a cross-sectional study on 4402 individuals from three Croatian cohorts. The aim of this study was to analyse the prevalence of diagnosed and undiagnosed hypothyroidism, hyperthyroidism (subclinical and clinical) and positive thyroid antibodies in the Croatian population. The results of the study indicated that 17.6% of participants were euthyroid with positive antibodies. The prevalence of clinical and subclinical hypothyroidism was 3% and 7.4%, respectively, while the prevalence of clinical and subclinical hyperthyroidism was 0.2% and 1.1%, respectively. Among them, 92.6% subclinical hypothyroid, 93.9% clinical hypothyroid, 83% subclinical hyperthyroid and 71.4% clinical hyperthyroid participants were undiagnosed. Finally, the prevalence of undiagnosed subclinical and clinical hypothyroidism in our population was 6.9% and 2.8%, respectively, while the prevalence of undiagnosed subclinical and clinical hyperthyroidism was 0.9% and 0.1%, respectively. Women showed a higher prevalence of thyroid disorders; 1.57 times higher odds of euthyroidism with positive antibodies, 2.1 times higher odds of subclinical hyperthyroidism, 2.37 times higher odds of clinical hypothyroidism and 1.58 times higher odds of subclinical hypothyroidism than men. These results indicate an extremely high proportion of undiagnosed cases, and therefore require investments in a prevention programme.
甲状腺功能障碍似乎是主要的内分泌疾病。我们对来自克罗地亚三个队列的4402名个体进行了一项横断面研究。本研究的目的是分析克罗地亚人群中已诊断和未诊断的甲状腺功能减退症、甲状腺功能亢进症(亚临床和临床)以及甲状腺抗体阳性的患病率。研究结果表明,17.6%的参与者甲状腺功能正常但抗体呈阳性。临床和亚临床甲状腺功能减退症的患病率分别为3%和7.4%,而临床和亚临床甲状腺功能亢进症的患病率分别为0.2%和1.1%。其中,92.6%的亚临床甲状腺功能减退症患者、93.9%的临床甲状腺功能减退症患者、83%的亚临床甲状腺功能亢进症患者和71.4%的临床甲状腺功能亢进症患者未被诊断。最后,我们人群中未诊断的亚临床和临床甲状腺功能减退症的患病率分别为6.9%和2.8%,而未诊断的亚临床和临床甲状腺功能亢进症的患病率分别为0.9%和0.1%。女性甲状腺疾病的患病率更高;甲状腺功能正常但抗体呈阳性的几率比男性高1.57倍,亚临床甲状腺功能亢进症的几率高2.1倍,临床甲状腺功能减退症的几率高2.37倍,亚临床甲状腺功能减退症的几率高1.58倍。这些结果表明未诊断病例的比例极高,因此需要投资开展预防项目。